Mahesh Choolani

Mahesh Choolani

Auto-generated profile, based on publicly available information

Mahesh Choolani

Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Level 12 NUHS Tower Block, 1E Kent Ridge Road, 119228, Singapore

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
HAHima C. S. Abeysinghe
Hima C. S. Abeysinghe
LBLaita Bokhari
Laita Bokhari
AQAnita Quigley
Anita Quigley
MCMahesh Choolani
Mahesh Choolani
JCJerry Chan
Jerry Chan
CRCarli Roulston
Carli Roulston
Introduction: Despite attempts to prevent brain injury during the hyperacute phase of stroke, most sufferers end up with significant neuronal loss and functional deficits. The use of cell-based therapies to recover the injured brain offers new hope. In the current study, we employed human neural stem cells (hNSCs) isolated from subventricular zone (SVZ), and directed their differentiation into GABAergic neurons followed by transplantation to ischemic brain. Methods: Pre-differentiated GABAergic neurons, undifferentiated SVZ-hNSCs or media alone were stereotaxically transplanted into the rat brain (n=7/group) 7 days after endothelin-1 induced stroke. Neurological outcome was assessed by neurological deficit scores and the cylinder test. Transplanted cell survival, cellular phenotype and maturation were assessed using immunohistochemistry and confocal microscopy. Results: Behavioral assessments revealed accelerated improvements in motor function 7 days post-transplant in rats treated with pre-differentiated GABAergic cells in comparison to media alone and undifferentiated hNSC treated groups. Histopathology 28 days-post transplant indicated that pre-differentiated cells maintained their GABAergic neuronal phenotype, showed evidence of synaptogenesis and up-regulated expression of both GABA and calcium signaling proteins associated with neurotransmission. Rats treated with pre-differentiated cells also showed increased neurogenic activity within the SVZ at 28 days, suggesting an additional trophic role of these GABAergic cells. In contrast, undifferentiated SVZ-hNSCs predominantly differentiated into GFAP-positive astrocytes and appeared to be incorporated into the glial scar. Conclusion: Our study is the first to show enhanced exogenous repopulation of a neuronal phenotype after stroke using techniques aimed at GABAergic cell induction prior to delivery that resulted in accelerated and improved functional recovery.

1 February 2017 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
ABAngela N. Barrett
Angela N. Barrett
RSRamasamy Saminathan
Ramasamy Saminathan
MCMahesh Choolani
Mahesh Choolani

19 September 2011 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
MKMandeep Kaur
Mandeep Kaur
CMCameron Ross MacPherson
Cameron Ross MacPherson
SSSebastian Schmeier
Sebastian Schmeier
KNKothandaraman Narasimhan
Kothandaraman Narasimhan
MCMahesh Choolani
Mahesh Choolani
VBVladimir Bajic
Vladimir Bajic
Background: Our study focuses on identifying potential biomarkers for diagnosis and early detection of ovarian cancer (OC) through the study of transcription regulation of genes affected by estrogen hormone. Results: The results are based on a set of 323 experimentally validated OC-associated genes compiled from several databases, and their subset controlled by estrogen. For these two gene sets we computationally determined transcription factors (TFs) that putatively regulate transcription initiation. We ranked these TFs based on the number of genes they are likely to control. In this way, we selected 17 top-ranked TFs as potential key regulators and thus possible biomarkers for a set of 323 OC-associated genes. For 77 estrogen controlled genes from this set we identified three unique TFs as potential biomarkers. Conclusions: We introduced a new methodology to identify potential diagnostic biomarkers for OC. This report is the first bioinformatics study that explores multiple transcriptional regulators of OC-associated genes as potential diagnostic biomarkers in connection with estrogen responsiveness. We show that 64% of TF biomarkers identified in our study are validated based on real-time data from microarray expression studies. As an illustration, our method could identify CP2 that in combination with CA125 has been reported to be sensitive in diagnosing ovarian tumors.

21 February 2017 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
TWTuangsit Wataganara
Tuangsit Wataganara
SSSuresh Seshadri
Suresh Seshadri
TLTak Yeung Leung
Tak Yeung Leung
CMCitra Matter
Citra Matter
MNMonawat Ngerncham
Monawat Ngerncham
MCMahesh Choolani
Mahesh Choolani
Objectives: The Management of Myelomeningocele Study (MOMS Trial) has inspired many fetal therapy centers (FTCs) to offer open fetal surgery for myelomeningocele (MMC). This is an initial effort to create a candidate model that can be applicable to many parts of Asia. Material and Methods: A limited selection of specialists from 4 established FTCs in Thailand, Hong Kong, India, and Singapore met for a round table discussion. Experts from Children's Hospital of Philadelphia (CHOP) involved in the Trial moderated the session. The practice suggestions in this statement were from a targeted literature review and expert opinion. Results: A high prevalence of MMC in Asia supports an effort to adopt the procedure, but only in established FTCs with good maternal and neonatal ancillary supports. The falling incidence of MMCs may affect case volume and maintenance of skill. A regional approach was recommended. Fetal benefits have to be weighed against maternal risks, with a consideration of recent outcome data from the endoscopic approach. Responsible FTCs need standardized diagnosis and management, with their long-term outcome data available for an audit. Conclusions: It is envisaged that the information presented by this multidisciplinary team would be useful for FTCs in Asia or elsewhere that plan to establish more advanced fetal care in the future.

31 May 2016 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
RJRebecca A. Jackson
Rebecca A. Jackson
MNMai Linh Nguyen
Mai Linh Nguyen
ABAngela N. Barrett
Angela N. Barrett
YTYuan Yee Tan
Yuan Yee Tan
MCMahesh A. Choolani
Mahesh A. Choolani
Ee Sin ChenEe Sin Chen
Ee Sin Chen

23 April 2013 in Singapore Medical Journal
Verified
Journal Article
Closed access
MCM Choolani
M Choolani
ABA Biswas
A Biswas